Systemic Inflammation, Survival of Prostate Cancer Patients

Conclusion

In conclusion, the results of the present study indicate that systemic inflammation-based prognostic scores, mGPS and NLR, have prognostic value in prostate cancer patients. However, in terms of differentiating high risk from low risk patients, the mGPS appeared to be superior to the NLR.